MAZE Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
MAZE Therapeutics Inc
TickerMAZE
CIK #0001842295
CUSIP578784100
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address171 Oyster Point Boulevard, Suite 300, South San Francisco, CA 94080
Source [EDGAR]
CIK Filing 2011 - 2025
[0001842295] 10-K
[0001842295] 10-Q
[0001842295] 3
[0001842295] 4
[0001842295] 8-K
[0001842295] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Arch Venture Fund X LP MAZE Therapeutics Inc [2025-05-15] 0.0
Matrix Capital Management Company LP MAZE Therapeutics Inc [2025-05-14] 0.0
Janus Henderson Group PLC MAZE Therapeutics Inc [2025-05-14] 0.0
Third Rock Ventures IV LP MAZE Therapeutics Inc [2025-05-09] 0.0
GV 2019 LP MAZE Therapeutics Inc [2025-05-09] 0.0
Frazier Life Sciences Public Fund LP MAZE Therapeutics Inc [2025-02-10] 0.0
Foresite Capital Fund IV LP MAZE Therapeutics Inc [2025-02-07] 0.0
Deep Track Capital LP MAZE Therapeutics Inc [2025-02-07] 0.0
Foresite Capital Fund IV LP MAZE Therapeutics Inc [2025-02-07] 0.0
Form 3/4/5 Filer 2011 - 2025
Exter Neil
Maze Therapeutics, Inc.
Third Rock Ventures IV, L.P.
Third Rock Ventures GP IV, L.P.
Third Rock Ventures V, L.P.
TRV GP V LLC
TRV GP IV LLC
Third Rock Ventures GP V, LP
Homcy Charles J
Lim Jonathan E
Bernstein Harold
Courtney Phillips
Andrews Nancy C
Brush James
Colowick Alan
Kathiresan Sekar
Scheller Richard H
Sohn Catherine A.
Spiegelman Daniel K
Tong Jeffrey K
ARCH Venture Fund X, L.P.
ARCH Venture Fund X Overage, L.P.
ARCH Venture Partners X, LLC
Crandell Keith
Gillis Steven
ARCH Venture Partners X, L.P.
ARCH Venture Partners X Overage, L.P.
Nelsen Robert
Burow Kristina
Coloma Jason V
Dandekar Atul
Bachrodt Amy
Form 13F Holdings
Firm Period DFND Voting Shares
TRV GP IV LLC [2025-06-30] SOLE 6,073,958 6,073,958
Frazier Life Sciences Management LP [2025-06-30] SOLE 4,567,275 4,567,275
Arch Venture Management LLC [2025-06-30] SOLE 0 4,120,053
Deep Track Capital LP [2025-06-30] SOLE 3,948,910 3,948,910
Matrix Capital Management Company LP [2025-06-30] SOLE 2,486,184 2,486,184
Alphabet Inc. [2025-06-30] DFND 0 2,412,471
Foresite Capital Management IV, LLC [2025-06-30] SOLE 2,111,919 2,111,919
Ah Capital Management LLC [2025-06-30] SOLE 1,702,225 1,702,225
Janus Henderson Group PLC [2025-06-30] DFND 0 1,401,260
General Catalyst Group Management LLC [2025-06-30] DFND 1,035,910 1,035,910
TRV GP V LLC [2025-06-30] SOLE 950,800 950,800
Woodline Partners LP [2025-06-30] SOLE 940,700 940,700
Casdin Capital LLC [2025-06-30] SOLE 758,857 758,857
Harvard Management Co Inc [2025-06-30] SOLE 637,528 637,528
BlackRock, Inc. [2025-06-30] SOLE 601,539 614,704
Logos Global Management LP [2025-06-30] SOLE 611,914 611,914
FMR LLC [2025-06-30] DFND 553,897 554,534
HHLR Advisors Ltd [2025-06-30] OTR 0 457,535
Vanguard Group Inc [2025-06-30] SOLE 0 412,014
Sphera Funds Management Ltd [2025-06-30] DFND 356,453 356,453
Foresite Capital Management V, LLC [2025-06-30] SOLE 345,191 345,191
Ikarian Capital LLC [2025-06-30] SOLE 262,740 262,740
Geode Capital Management LLC [2025-06-30] DFND 231,237 231,237
Driehaus Capital Management LLC [2025-06-30] SOLE 193,400 193,400
Octagon Capital Advisors LP [2025-06-30] SOLE 177,667 177,667
State Street Corp [2025-06-30] DFND 132,863 144,685
Alyeska Investment Group LP [2025-06-30] SOLE 125,000 125,000
Northern Trust Corp [2025-06-30] DFND 84,260 84,260
Boothbay Fund Management LLC [2025-06-30] OTR 0 75,530
Charles Schwab Investment Management Inc [2025-06-30] SOLE 75,171 75,171
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com